Article
Neuroendocrine tumours: cracking the epigenetic code
21 Feb 2013
Abstract excerpt
The field of epigenetics has evolved rapidly over recent years providing insight into the tumorigenesis of many solid and haematological malignancies. Determination of epigenetic modifications in neuroendocrine tumour (NET) development is imperative if we are to improve our understanding of the biology of this heterogenous group of tumours. Epigenetic marks such as DNA methylation at RASSF1A are frequent findings...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
